[1
]
Jeffrey A. Meyerhardt and Deborah H. Schrag, Dana-Farber Cancer Institute, Boston,
MA; Pamela B. Mangu, American Society of Clinical Oncology; Kim Ryan, Fight Colorectal
Cancer, Alexandria, VA; Patrick J. Flynn, Minnesota Oncology, Minneapolis; Charles
L. Loprinzi, Mayo Clinic, Rochester, MN; Larissa Korde, University of Washington,
Seattle, WA; Bruce D. Minsky, MD Anderson Cancer Center, Houston, TX; Nicholas J.
Petrelli, Helen Graham Cancer Center, Newark, DE; Sandra L. Wong, University of Michigan
Medical School, Ann Arbor, MI; and Al B. Benson III, Lurie Comprehensive Cancer Center,
Northwestern University, Chicago, IL.